Mar 07, 2022 / 03:30PM GMT
Steven Mah - Cowen and Company - Analyst
Hello, good morning, everyone. As a reminder, the chat feature is disabled, so please email questions and I'll try to address them as we go in real time. As a reminder, my email address is [email protected], and that is Steven with a V.
So, our next panel today is focused on the exciting synthetic biology space. Similar to other transformational technologies like the Internet, mobile computing, etc., we believe synthetic biology will become one of the most important technologies of our time with the ability to develop more applications across almost all industries in ways we can't even envision today.
So, I want to kick off the session by saying our panel today is focused on tools, which are interrogating biological systems. So, as such the applications are much broader than just a synthetic biology application. These tools are also used as a horizontal service for synthetic biology companies who are either in engineering cells themselves or developing products or applications. So again, the products can be for many end markets; one of them
Twist Bioscience Corp at Cowen Health Care Conference (Virtual) - Synthetic Biology Enabling Technologies Panel Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
